Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
43.01
-0.14 (-0.32%)
At close: Feb 27, 2026, 4:00 PM EST
43.42
+0.41 (0.95%)
After-hours: Feb 27, 2026, 7:20 PM EST
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $3.38 billion as of February 27, 2026. Its market cap has increased by 182.25% in one year.
Market Cap
3.38B
Enterprise Value
2.62B
1-Year Change
182.25%
Ranking
Category
Stock Price
$43.01
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $3.38B, an increase of 2,924.18%. That is a compound annual growth rate of 41.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.38B | 32.89% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.91B |
| Corcept Therapeutics | 3.80B |
| ADMA Biologics | 3.71B |
| Alumis | 3.70B |
| Xenon Pharmaceuticals | 3.60B |
| Legend Biotech | 3.51B |
| Denali Therapeutics | 3.36B |
| Arcutis Biotherapeutics | 3.35B |